Walgreens Boots Alliance, Inc. (WBA)
| Market Cap | 9.65B |
| Revenue (ttm) | 150.41B |
| Net Income (ttm) | -8.83B |
| Shares Out | 864.74M |
| EPS (ttm) | -10.24 |
| PE Ratio | n/a |
| Forward PE | 7.49 |
| Dividend | n/a |
| Ex-Dividend Date | Nov 18, 2024 |
| Volume | 2,413,968 |
| Open | 11.11 |
| Previous Close | 11.16 |
| Day's Range | 11.11 - 11.17 |
| 52-Week Range | 8.08 - 19.48 |
| Beta | 0.64 |
| Analysts | Hold |
| Price Target | 10.59 (-5.07%) |
| Earnings Date | Apr 8, 2025 |
About WBA
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of p... [Read more]
Financial Performance
In 2024, Walgreens Boots Alliance's revenue was $147.66 billion, an increase of 6.17% compared to the previous year's $139.08 billion. Losses were -$8.64 billion, 180.4% more than in 2023.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for WBA stock is "Hold." The 12-month stock price forecast is $10.59, which is a decrease of -5.07% from the latest price.
News
Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Walgreens Settles Allegations of Submitting Inflated Prices to Medicaid Programs
Walgreens has agreed to pay $2.8 million to settle allegations that it submitted inflated prices to the Massachusetts and Georgia Medicaid programs for generic medications.
Walgreens to pay more than $2.85 million to settle US overbilling charges
Walgreens will pay more than $2.85 million to settle whistleblower allegations that the pharmacy overbilled Medicaid programs in Georgia and Massachusetts for generic medications, the U.S. Department ...
Walgreens Agrees to Pay About $2.8 Million to Resolve Medicaid-Overbilling Allegations
Walgreens agreed to pay about $2.8 million to the federal government and the states of Massachusetts and Georgia to settle allegations that the company inflated prices for generic medications covered ...
Walgreens Boots' Stefano Pessina to almost double stake after Sycamore takeover, FT reports
Walgreens Boots Alliance's executive chair Stefano Pessina will almost double his stake in the US pharmacy group to about 30% as part of its takeover by private equity group Sycamore, the Financial Ti...
The drugstore industry is struggling. Here's what could be in its future.
Nearly a third of the U.S. retail pharmacies that were open from 2010 to 2020 had shuttered by 2021, study finds.
Walgreens Boots Alliance: A Great Risk To Reward Opportunity With This $23.7 Billion Buyout
Walgreens Boots Alliance is being acquired by Sycamore Partners, causing shares to rise 7.5% to $11.39, though long-term shareholders face a 50.2% loss since January 2024. The deal includes a $23.7 bi...
The Walgreens Billionaire Watching His Empire Come Apart
From Monaco, Stefano Pessina built a retailer valued at about $100 billion. It agreed to go private this week for roughly $10 billion.
The Score: Toyota Motor, Walgreens Boots Alliance, Gap and More Stocks That Defined the Week
Here are some of the major companies whose stocks moved on the week's news.
Walgreens stock gets a modest boost after the pharmacy chain agrees to be bought by private equity
Shares in Walgreens Boots Alliance, Inc. (Nasdaq: WBA) are up a modest amount after the company announced yesterday that it has agreed to be purchased by private equity firm Sycamore Partners. As of t...
Faber Report: Walgreens to go private
David Faber breaks down the latest details on Sycamore's acquisition of Walgreens.
Walgreens Goes From $100 Billion Health Giant to Private-Equity Salvage Project
Sycamore's deal to take Walgreens private follows the storied chain's decline amid e-commerce and health-industry changes.
Walgreens to go private in $10B deal with Sycamore: how the pharmacy giant fell from grace
Walgreens Boots Alliance will be taken private by Sycamore Partners in a $10 billion deal, the companies announced Thursday, marking the end of nearly a century of public trading for the US pharmacy g...
Walgreens, from pharmacy behemoth to distressed retailer
Walgreens Boots Alliance is being taken private by Sycamore Partners for $10 billion, bringing to a close the pharmacy chain operator's nearly century-long association with the public markets.
Walgreens Agrees to Acquisition by Sycamore Partners
Walgreens Boots Alliance (WBA) said Thursday (March 6) that it has entered into a definitive agreement to be acquired by an entity affiliated with private equity firm Sycamore Partners.
Walgreens Agrees To Be Taken Private in $10B Deal
Walgreens Boots Alliance (WBA) said Thursday it agreed to be taken private in a $10 billion deal with private equity firm Sycamore Partners.
Walgreens to be taken private by Sycamore Partners in $10B deal
Sycamore will pay $11.45 per share, a premium of 8% to the stock's closing price.
Walgreens to go private in $10B deal
Walgreens Boots Alliance on Thursday entered into an agreement with private equity firm Sycamore Partners to go private. The deal is valued at $10 billion.
Here's when Walgreens will go private after its $10 billion private-equity buyout
After nearly a century as a publicly traded company, drugstore chain Walgreens is going private as part of a roughly $10 billion buyout deal.
Walgreens To Be Acquired By Private Equity Firm For Almost $10 Billion
Walgreens has been a public company since 1927.
Walgreens strikes deal to be taken private, according to WSJ
CNBC's Seema Mody talks report Walgreen's made a deal with Sycamore Partners to go private.
Walgreens to go private in roughly $10 billion deal with Sycamore Partners
Walgreens said it inked a deal with private equity firm Sycamore Partners that will take it off the public market for an equity value of around $10 billion. The historic transaction ends Walgreens' tu...
Walgreens to be taken private by Sycamore Partners in $10 billion deal, WSJ reports
Walgreens Boots Alliance will be taken private by Sycamore Partners for $10 billion, the Wall Street Journal reported on Thursday.
Walgreens Boots Alliance Enters into Definitive Agreement to Be Acquired by Sycamore Partners
DEERFIELD, Ill. & NEW YORK--(BUSINESS WIRE)--Walgreens Boots Alliance (NASDAQ: WBA) (the "Company" or “WBA”) today announced that it has entered into a definitive agreement to be acquired by an entity...